Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
NASDAQ
20.031,13
1,35%
Bitcoin
98.122,48
-0,56%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ IDEAYA Biosciences Inc (IDYA) IDEAYA Biosciences Inc (IDYA) Notizie

IDEAYA Biosciences Inc

IDYA
25,30
-0,08 (-0,32%)
24 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
20/12/202422:53EDGAR2Form 3 - Initial statement of beneficial ownership of..
17/12/202412:00PRNUSIDEAYA Announces IDMC Recommendation of Move-Forward Dose in..
16/12/202412:00PRNUSIDEAYA Announces Development Candidate Nomination of IDE251,..
11/12/202412:00PRNUSIDEAYA Announces Agenda for Investor R&D Day Webcast on..
10/12/202412:00PRNUSIDEAYA Announces First-Patient-In for Phase 1 Clinical Trial..
09/12/202412:00PRNUSIDEAYA Biosciences Announces Development Candidate..
06/12/202412:00PRNUSIDEAYA Biosciences Announces Inducement Grants under Nasdaq..
02/12/202412:00PRNUSIDEAYA Biosciences Announces Participation in Upcoming..
29/11/202412:00PRNUSIDEAYA Biosciences Announces Inducement Grants under Nasdaq..
18/11/202412:00PRNUSIDEAYA Biosciences Appoints Stu Dorman as Chief Commercial..
12/11/202412:00PRNUSIDEAYA Biosciences Announces Participation in Jefferies..
11/11/202416:40BWBiocytogen annonce la nomination par IDEAYA du candidat..
11/11/202412:00PRNUSIDEAYA Announces Development Candidate Nomination of IDE034,..
04/11/202414:30PRNUS/C O R R E C T I O N -- IDEAYA Biosciences, Inc./
04/11/202412:03EDGAR2Form 8-K - Current report
04/11/202412:00PRNUSIDEAYA Biosciences, Inc. Reports Third Quarter 2024..
01/11/202411:00PRNUSIDEAYA Biosciences Announces Inducement Grants under Nasdaq..
28/10/202411:00PRNUSIDEAYA Biosciences Announces IND-Clearance for Werner..
25/10/202412:04EDGAR2Form 8-K - Current report
25/10/202412:00PRNUSIDEAYA Announces Positive Interim Phase 1 Expansion Data of..
04/10/202422:01EDGAR2Form 8-K - Current report
04/10/202412:00PRNUSIDEAYA Biosciences Announces Late-Breaker Oral Presentation..
27/9/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202422:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/9/202412:00PRNUSIDEAYA Biosciences Announces Inducement Grants under Nasdaq..
23/9/202412:12EDGAR2Form 8-K - Current report
23/9/202412:00PRNUSIDEAYA Biosciences Announces Positive Interim Phase 2 Data..
22/9/202415:00PRNUSIDEAYA Announces Webcast to Report Interim Phase 2 Data for..
18/9/202412:00PRNUSIDEAYA Biosciences Appoints Douglas B. Snyder as Senior Vice..
30/8/202412:00PRNUSIDEAYA Biosciences Announces Inducement Grants under Nasdaq..
26/8/202423:16EDGAR2Form 144 - Report of proposed sale of securities
26/8/202412:00PRNUSIDEAYA Biosciences to Participate in the Morgan Stanley 22nd..
23/8/202412:00PRNUSIDEAYA Biosciences Announces Inducement Grants under Nasdaq..
06/8/202423:08EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/8/202422:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202412:04EDGAR2Form 8-K - Current report
06/8/202412:00PRNUSIDEAYA Biosciences, Inc. Reports Second Quarter 2024..
01/8/202401:56BW百奧賽圖宣布與IDEAYA..
31/7/202412:03EDGAR2Form 8-K - Current report
31/7/202412:00BW百奥赛图宣布与IDEAYA..
29/7/202412:00PRNUSIDEAYA Biosciences to Participate in Upcoming August 2024..
11/7/202422:12EDGAR2Form 8-K - Current report
11/7/202422:05PRNUSIDEAYA Announces Closing of Public Offering Including Full..
10/7/202423:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/7/202404:26PRNUSIDEAYA Announces Pricing of Public Offering
09/7/202423:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/7/202422:11EDGAR2Form 8-K - Current report
09/7/202422:08PRNUSIDEAYA Announces Proposed Public Offering of Common Stock..
08/7/202412:37IHMARKETNEWSParamount-Skydance $28B Merger, Boeing Agrees to Plead..
08/7/202412:04EDGAR2Form 8-K - Current report
Apertura: 25,50 Min: 24,97 Max: 26,00
Chiusura: 25,38

La tua Cronologia

NASDAQ
IDYA
IDEAYA Biosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network